Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer's disease like pathology

BMC Neuroscience

Volumn 16, Issue 1, 2015, Pages

  Arisi, Ivan ^a   D'Onofrio, Mara ^a   Brandi, Rossella ^a   Cattaneo, Antonino ^a,b   Bertolazzi, Paola ^c   Cumbo, Fabio ^c   Felici, Giovanni ^c   Guerra, Concettina ^c,d  

^a EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c CNR   (Italy)

^d Georgia Institute of Technology   (United States)

Author keywords

AD11 mouse model; Alzheimers disease; Correlation; Network; Neurodegeneration; NGF; Protein complex; Protein protein interaction

Indexed keywords

NERVE GROWTH FACTOR ANTIBODY;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; MATHEMATICAL ANALYSIS; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION; PROTEIN MISFOLDING; AGING; ANIMAL; BRAIN; DISEASE MODEL; FEMALE; GENE EXPRESSION; METABOLISM; MICROARRAY ANALYSIS; PROCEDURES; PROTEIN DATABASE; TIME FACTOR; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; DATABASES, PROTEIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MICE, TRANSGENIC; MICROARRAY ANALYSIS; TIME FACTORS;

EID: 84929440972     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/s12868-015-0155-5     Document Type: Article

References (82)

1. Bertolazzi P, Bock ME, Guerra C. On the functional and structural characterization of hubs in protein-protein interaction networks. Biotechnol Adv. 2013;31:274-86
2. Levy ED, Pereira-Leal JB. Evolution and dynamics of protein interactions and networks. Curr Opin Struct Biol. 2008;18:349-57
3. Przytycka TM, Singh M, Slonim DK. Toward the dynamic interactome: it's about time. Brief Bioinform. 2010;11:15-29
4. Stelzl U, Wanker EE. The value of high quality protein-protein interaction networks for systems biology. Curr Opin Chem Biol. 2006;10:551-8
5. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell. 2011;144:986-98
6. Jansen R, Greenbaum D, Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res. 2002;12:37-46
7. Tuncbag N, Kar G, Gursoy A, Keskin O, Nussinov R. Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example. Mol Biosyst. 2009;5:1770-8
8. de Lichtenberg U, Jensen LJ, Brunak S, Bork P. Dynamic complex formation during the yeast cell cycle. Science. 2005;307:724-7
9. Srihari S, Leong HW. Temporal dynamics of protein complexes in PPI networks: a case study using yeast cell cycle dynamics. BMC Bioinf. 2012;17(13 Suppl):S16
10. Tang X, Wang J, Liu B, Li M, Chen G, Pan Y. A comparison of the functional modules identified from time course and static PPI network data. BMC Bioinf. 2011;12:339
11. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol. 2009;27:199-204
12. Wang J, Peng X, Li M, Pan Y. Construction and application of dynamic protein interaction network based on time course gene expression data. Proteomics. 2013;13:301-12
13. Vlasblom J, Wodak SJ. Markov clustering versus affinity propagation for the partitioning of protein interaction graphs. BMC Bioinf. 2009;10:99
14. Palla G, Derenyi I, Farkas I, Vicsek T. Uncovering the overlapping community structure of complex networks in nature and society. Nature. 2005;435:814-8
15. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf. 2003;4:2
16. Ciriello G, Mina M, Guzzi PH, Cannataro M, Guerra C. AlignNemo: a local network alignment method to integrate homology and topology. PLoS One. 2012;7:e38107
17. Arisi I, D'Onofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G, et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J Alzheimers Dis. 2011;24:721-38
18. D'Onofrio M, Arisi I, Brandi R, Di Mambro A, Felsani A, Capsoni S, et al. Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice. Neurobiol Aging. 2011;32:1007-22
19. Capsoni S, Brandi R, Arisi I, D'Onofrio M, Cattaneo A. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol Disord Drug Targets. 2011;10:635-47
20. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci. 2000;20:2589-601
21. Fujiyama S, Yanagida M, Hayano T, Miura Y, Isobe T, Fujimori F, et al. Isolation and proteomic characterization of human Parvulin-associating preribosomal ribonucleoprotein complexes. J Biol Chem. 2002;277:23773-80
22. Mueller JW, Bayer P. Small family with key contacts: par14 and par17 parvulin proteins, relatives of pin1, now emerge in biomedical research. Perspect Medicin Chem. 2008;2:11-20
23. Ando K, Dourlen P, Sambo AV, Bretteville A, Belarbi K, Vingtdeux V, et al. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker. Neurobiol Aging. 2013;34:757-69
24. Kimura T, Tsutsumi K, Taoka M, Saito T, Masuda-Suzukake M, Ishiguro K, et al. Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclindependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J Biol Chem. 2013;288:7968-77
25. Pastorino L, Ma SL, Balastik M, Huang P, Pandya D, Nicholson L, et al. Alzheimer's disease-related loss of Pin1 function influences the intracellular localization and the processing of AbetaPP. J Alzheimers Dis. 2012;30:277-97
26. Wang JZ, Zhang YH, Sun XW, Li YL, Li SR, Zhang Y, et al. Focusing on the structure and the function of Pin1: new insights into the opposite effects of fever on cancers and Alzheimer's disease. Med Hypotheses. 2013;81:282-4
27. Jung C, Mittler G, Oswald F, Borggrefe T. RNA helicase Ddx5 and the noncoding RNA SRA act as coactivators in the Notch signaling pathway. Biochim Biophys Acta. 1833;2013:1180-9
28. Ghosh S, Thakur MK. Interaction of estrogen receptor-alpha transactivation domain with nuclear proteins of mouse brain: p68 RNA helicase shows ageand sex-specific change. J Neurosci Res. 2009;87:1323-8
29. Arun G, Akhade VS, Donakonda S, Rao MR. mrhl RNA, a long noncoding RNA, negatively regulates Wnt signaling through its protein partner Ddx5/p68 in mouse spermatogonial cells. Mol Cell Biol. 2012;32:3140-52
30. Wang R, Jiao Z, Li R, Yue H, Chen L. p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-kappaB transcription factor p50. Neuro Oncol. 2012;14:1116-24
31. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X, et al. RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol Cell Biol. 2011;31:1812-21
32. Agholme L, Nath S, Domert J, Marcusson J, Kagedal K, Hallbeck M. Proteasome inhibition induces stress kinase dependent transport deficits-implications for Alzheimer's disease. Mol Cell Neurosci. 2014;58:29-39
33. Chesser AS, Pritchard SM, Johnson GV. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol. 2013;4:122
34. Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24-49
35. Saido T, Leissring MA. Proteolytic degradation of amyloid beta-protein. Cold Spring Harb Perspect Med. 2012;2:a006379
36. Cecarini V, Bonfili L, Amici M, Angeletti M, Keller JN, Eleuteri AM. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Brain Res. 2008;1209:8-18
37. Orre M, Kamphuis W, Dooves S, Kooijman L, Chan ET, Kirk CJ, et al. Reactive glia show increased immunoproteasome activity in Alzheimer's disease. Brain. 2013;136:1415-31
38. Yen SS. Proteasome degradation of brain cytosolic tau in Alzheimer's disease. Int J Clin Exp Pathol. 2011;4:385-402
39. Ferrington DA, Gregerson DS. Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl Sci. 2012;109:75-112
40. Foss GS, Larsen F, Solheim J, Prydz H. Constitutive and interferon-gammainduced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1. Biochim Biophys Acta. 1998;1402:17-28
41. Hussong SA, Kapphahn RJ, Phillips SL, Maldonado M, Ferrington DA. Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem. 2010;113:1481-90
42. Heink S, Ludwig D, Kloetzel PM, Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A. 2005;102:9241-6
43. Jia Y, Song T, Wei C, Ni C, Zheng Z, Xu Q, et al. Negative regulation of MAVS-mediated innate immune response by PSMA7. J Immunol. 2009;183:4241-8
44. Hu XT, Chen W, Zhang FB, Shi QL, Hu JB, Geng SM, et al. Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration. Oncol Rep. 2009;22:1247-52
45. Berhane S, Areste C, Ablack JN, Ryan GB, Blackbourn DJ, Mymryk JS, et al. Adenovirus E1A interacts directly with, and regulates the level of expression of, the immunoproteasome component MECL1. Virology. 2011;421:149-58
46. Aso E, Lomoio S, Lopez-Gonzalez I, Joda L, Carmona M, Fernandez-Yague N, et al. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease. Brain Pathol. 2012;22:636-53
47. Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, et al. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol Aging. 2006;27:54-66
48. Tsai KL, Tomomori-Sato C, Sato S, Conaway RC, Conaway JW, Asturias FJ. Subunit architecture and functional modular rearrangements of the transcriptional mediator complex. Cell. 2014;157:1430-44
49. Carlsten JO, Zhu X, Gustafsson CM. The multitalented Mediator complex. Trends Biochem Sci. 2013;38:531-7
50. Schiano C, Casamassimi A, Vietri MT, Rienzo M, Napoli C. The roles of mediator complex in cardiovascular diseases. Biochim Biophys Acta. 1839;2014:444-51
51. Wang X, Yang N, Uno E, Roeder RG, Guo S. A subunit of the mediator complex regulates vertebrate neuronal development. Proc Natl Acad Sci U S A. 2006;103:17284-9
52. Lande-Diner L, Boyault C, Kim JY, Weitz CJ. A positive feedback loop links circadian clock factor CLOCK-BMAL1 to the basic transcriptional machinery. Proc Natl Acad Sci U S A. 2013;110:16021-6
53. Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest. 2013;123:5389-400
54. Lariviere L, Plaschka C, Seizl M, Wenzeck L, Kurth F, Cramer P. Structure of the Mediator head module. Nature. 2012;492:448-51
55. Furumoto T, Tanaka A, Ito M, Malik S, Hirose Y, Hanaoka F, et al. A kinase subunit of the human mediator complex, CDK8, positively regulates transcriptional activation. Genes Cells. 2007;12:119-32
56. Soreq H. Novel roles of non-coding brain RNAs in health and disease. Front Mol Neurosci. 2014;7:55
57. Kong Y, Wu J, Yuan L. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model. Curr Alzheimer Res. 2014;11:882-91
58. Rodriguez-Ortiz CJ, Baglietto-Vargas D, Martinez-Coria H, LaFerla FM, Kitazawa M. Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice. J Alzheimers Dis. 2014;42:1229-38
59. Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, et al. Circulating miRNAs as potential biomarkers in Alzheimer's disease. J Alzheimers Dis. 2014;42:1261-7
60. Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J Alzheimers Dis. 2014;40:1017-27
61. Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, et al. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med. 2013;5:1613-34
62. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28:1213-23
63. Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, et al. Altered microRNA regulation in Huntington's disease models. Exp Neurol. 2011;227:172-9
64. Hebert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN, et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet. 2010;19:3959-69
65. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 1991;7:337-47
66. El Ghazi I, Martin BL, Armitage IM. New proteins found interacting with brain metallothionein-3 are linked to secretion. Int J Alzheimers Dis. 2010;2011:208634
67. Luo Y, Xu Y, Bao Q, Ding Z, Zhu C, Huang ZX, et al. The molecular mechanism for human metallothionein-3 to protect against the neuronal cytotoxicity of Abeta(1-42) with Cu ions. J Biol Inorg Chem. 2013;18:39-47
68. Manso Y, Carrasco J, Comes G, Meloni G, Adlard PA, Bush AI, et al. Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease. Cell Mol Life Sci. 2012;69:3683-700
69. Slaymaker IM, Chen XS. MCM structure and mechanics: what we have learned from archaeal MCM. Subcell Biochem. 2012;62:89-111
70. Bonda DJ, Evans TA, Santocanale C, Llosa JC, Vina J, Bajic V, et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany NY). 2009;1:382-8
71. Schrotter A, Mastalski T, Nensa FM, Neumann M, Loosse C, Pfeiffer K, et al. FE65 regulates and interacts with the Bloom syndrome protein in dynamic nuclear spheres-potential relevance to Alzheimer's disease. J Cell Sci. 2013;126:2480-92
72. Frade JM, Ovejero-Benito MC. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle. 2015;14:712-20
73. Takata K, Kitamura Y, Nakata Y, Matsuoka Y, Tomimoto H, Taniguchi T, et al. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease. Am J Pathol. 2009;175:17-24
74. Yamamoto A, Behl C. Human Nck-associated protein 1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation. Neurosci Lett. 2001;316:50-4
75. Kikugawa S, Nishikata K, Murakami K, Sato Y, Suzuki M, Altaf-Ul-Amin M, et al. PCDq: human protein complex database with quality index which summarizes different levels of evidences of protein complexes predicted from h-invitational protein-protein interactions integrative dataset. BMC Syst Biol. 2012;6 Suppl 2:S7
76. Liu CT, Yuan S, Li KC. Patterns of co-expression for protein complexes by size in Saccharomyces cerevisiae. Nucleic Acids Res. 2009;37:526-32
77. Tornow S, Mewes HW. Functional modules by relating protein interaction networks and gene expression. Nucleic Acids Res. 2003;31:6283-9
78. Laganowsky A, Reading E, Hopper JT, Robinson CV. Mass spectrometry of intact membrane protein complexes. Nat Protoc. 2013;8:639-51
79. Cattaneo A, Rapposelli B, Calissano P. Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. J Neurochem. 1988;50:1003-10
80. Covaceuszach S, Cassetta A, Konarev PV, Gonfloni S, Rudolph R, Svergun DI, et al. Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody. J Mol Biol. 2008;381:881-96
81. Ruepp A, Brauner B, Dunger-Kaltenbach I, Frishman G, Montrone C, Stransky M, et al. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res. 2008;36:D646-50
82. Hovatta I, Zapala MA, Broide RS, Schadt EE, Libiger O, Schork NJ, et al. DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: implications for eQTL mapping studies. Genome Biol. 2007;8:R25